Objective: To determine the value of neutrophil-lymphocyte ratio for predicting high-grade dysplasia among patients with neoplastic colorectal polyp.
INTRODUCTION
Colorectal polyps are histologically classified as neoplastic and non-neoplastic. Most colorectal cancers (CRCs) develop from neoplastic polyps (NPs) named as adenomatous polyps (adenomas) (1) . It takes 10 years for a NP smaller than 1 cm to transform the CRC and NPs are usually asymptomatic (2) . It is recognized that more than 95% of all CRCs develop from NPs (1) . The risk of an adenoma becoming malignant is the greatest for advanced adenoma defined as adenoma with size ≥ 1 cm, villous elements, or high grade dysplasia (HGD) (3) . CRC screening guidelines recommend follow-up surveillance examinations to detect additional new adenomas, missed synchronous adenomas and advanced neoplasia after polypectomy (3) . It is suggested that patients with advanced adenomas should have their next follow-up colonoscopy in 3 years and patients with low risk adenomas should be screened 5-yearly until one negative colonoscopy examination then cease surveillance (3) . All NPs have variable degrees of dysplasia ranging from low-grade to high-grade. HGD contains the histological changes previously called ''carcinoma in situ'' or intramucosal carcinoma.'' Of all patients with adenomas, 5-7% have HGD (1) . An adenoma with HGD have higher risk for CRC than an adenoma without it (1) (2) (3) . Recently, it has been shown that chronic inflammation was a risk factor for CRC (4) and Glasgow prognostic score, an inflammation-based prognostic score including the serum C-reactive protein and albumin level, was a good independent prognostic factor in patients with CRC (5).
Neutrophil-lymphocyte ratio (NLR) was an inflammation index and recently gain a prognostic value for patients with CRC (6). NLR could be used in patients with CRC for stratification of the patients, adjusting the treatment strategy and tumor staging (6, 7) . Mean platelet volume (MPV) was an inflammatory marker in chronic illness and found to be lower in patients with ankylosing spondylitis and rheumatoid arthritis than controls (8) .
Contraversely in patients with CRC it has been found that MPV was higher in patients with colon cancer than controls and elevated MPV was associated with colon cancer (9) . Red blood cell distribution width (RDW) is part of an automated complete blood count and the most commonly reported index to determine the anisocytosis in red cell volume (10) . Recent studies have showed the relationship between high RDW levels and inreased mortality in the general population (11) and in patients with hepatitis B (12) . It was reported that RDW is associated with inflammatory marker in lung cancer (13) . Another study reported that RDW was found to be 84% sensitive and 88% specific for right-sided colon cancer (14) . It was reported that colorectal adenomas had an increased inflammation (15) . Recently a study reported that NLR may be a biomarker for determining neoplastic colorectal polyp (16) . To date, relationship between HGD and NLR in patients with neoplastic colorectal polyps has not been evaluated. The aim of this study was to determine the value of NLR which is a simple index calculated by using routine laboratory data for predicting HGD among patients with neoplastic colorectal polyp. Descriptive statistics were expressed as mean ± standard deviation for discrete numeric variables and as number or percentage of cases for categorical variables. Significance of differences of average values between groups was assessed by Student's t test when there were two independent groups and by One-Way ANOVA when there were more than two independent groups. Receiver operating characteristic (ROC) curve analysis with 95% confidence intervals (CI) was used to establish optimal cut-off values of NLR for detection of HGD and NPs in all polyps. The sensitivity and specificity were calculated to determine the diagnostic accuracy of the model. A p value of 0.05 was considered to indicate statistical significance.
MATERIAL AND METHODS

Laboratory
RESULTS
We evaluated 91 patients with colorectal polyp and 30 patients with normal colonoscopy as control group (15 males and 15 females). Among a total of 91 patients with polyp, 51.6%
were males and 48.4% were females (n=47/44, respectively). The mean age of the patients was 62.2114.39 years and the mean age of the control was 57.678.80 years. The patients' descriptive characteristics were demonstrated in Table 1 . (Figure 3) . No statistically significant differences were observed between the groups according to MPV(p=0.715) and RDW (p=0.692). The cut-of value of NLR to distinguish the presence of HGD was 2.044 (sensitivity: 69%, specificity: 68%) and the AUC was 0.63 (95% CI 0.49-0.78) for NLR. 
DISCUSSION
Adenoma is the most common lesion detected in CRC screening and the most CRCs develop from normal mucosa to adenoma and then to carcinoma (17) . The data of National Polyp Study, a large longitudinal study on surveillance of adenoma patients, showed that there was a reduction by 76-90% in development of CRC following colonoscopic polypectomy (18) .
Adenomas with advanced characteristics (>1 cm in diameter, with HGD, with villous histology) were the highest risk factor for malignancy (3) and HGD also was a predictor of adenoma recurrence (19) . A meta-analysis reported by Saini et al. (20) with CRC and suggested that NLR could be monitored in patients with CRC for stratification of the patients and identifying the treatment strategy. NLR has not only been studied in patients with CRC and also in patients with gastric cancer. Recent study has shown the NLR as a prognostic marker in patients with gastric cancer (26) . Again, to the best of our knowledge, there has been no study about relationship between NLR and HGD in neoplastic colorectal polyp in English literature. Karaman and et al. (16) showed that NLR may be used for identifying the NP from others. In this study HGD was not evaluated and there was no control group. Our study demonstrated that mean NLR of patients with NP was higher than patients with non-neoplastic and control group and can be a usefull noninvasive index to predict NP and HGD in a patient with neoplastic colorectal polyp. The present study was the first study showing NLR as a marker for determining HGD in patients with neoplastic colorectal polyp. Recently, researchers investigated some parameters of complete blood count to find an inexpansive and simple biomarker for determining the disease activity, cancer or response to the treatment in solid tumors. MPV and RDW were evaluated for these reasons.
The relationship between MPV and colon cancer was reported and MPV was higher in patients with colon cancer than control group (9) . Otherwise recent studies were found that MPV was decreased in acute stage of the rheumatic fever (27), in patients with arthritis of SLE activation (28) and acute pancreatitis (29) . RDW, the other parameter of the complete blood count, was evaluated in most studies. Spell and et al. (14) reported that RDW may be usefull for detecting right-sided CRC. Recent study supported that opinion and suggested that RDW can be used as an early warning biomarker for colon cancer (30). Cengiz and et al (31) evaluated RDW in patients with non-alcoholic steatohepatitis and demonstrated that RDW can identify the presence of non-alcoholic steatohepatitis and advanced fibrotic score. Also it was shown that RDW can predict survival in patients with hepatocellular carcinoma (32) .
Relationship between MPV, RDW and inflammation was demonstrated and recent study suggested that colorectal adenomas had an increased inflammation (15) . We identified the hypothesis that MPV and RDW could determine HGD in patients with colorectal polyp. We found that MPV may be predict the NP but it was not usefull for determining HGD. We also showed that RDW was impractical for identifying NP and HGD. There was not a good biomarker for determining NP because of this further studies are needed to confirm the predictive effect of MPV on determining NP.
CONCLUSION
To date, there has been no effective biomarker in distinguishing colorectal polyp for determining HGD. To the best of our knowledge, the present study was the first one evaluating the role of NLR for determining HGD in patients with colorectal polyp. NLR which is a simple noninvasive index easily calculated from completed blood count can identify HGD and NP. Although, MPV and RDW are not usefull for identifying high-grade dysplasia in patients with colorectal polyp, MPV may determine the neoplastic polyp.
